NCT04093570 2025-10-31A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)Taiho Oncology, Inc.Phase 2 Enrolling by invitation332 enrolled
NCT06788509 2025-10-10A Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringJanssen Research & Development, LLCPhase 1 Enrolling by invitation80 enrolled